Podcast
AI Access Brief Podcast
Hosted by Carl Haakon · EN
AI Generated Daily briefings on HEOR, HTA strategy and the evidence access landscape. For pharmaceutical and biotech professionals navigating regulatory-payer alignment, HTA submissions, and evidence strategy.
68episodes
Episodes
Newest firstAll episodes
Market Access Crosscurrents
Yesterday00:09:58Tap to summarizeEpisode 74 — 01 August 2026 Examining HCA's profit warning signals, subcutaneous Leqembi's HEOR path, FTC insulin pricing impact, and ICER's expanded scientific advice. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →HTA Alignment & Gene Therapy Value
4d ago00:07:23Tap to summarizeEpisode 73 — 29 July 2026 Examining CMS Part D implementation challenges, ICER's novel Alzheimer's endpoints, EMA's adaptive pathway expansion, and FDA's gene therapy breakthrough updates. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →HCA Profit Warning & Insulin Pricing Shifts
5d ago00:08:02Tap to summarizeEpisode 72 — 28 July 2026 HCA's uninsured surge signals systemic access challenges; subQ Leqembi reshapes Alzheimer's evidence needs; FTC insulin settlement alters PBM dynamics; ICER's Evidence First program redefines early engagement. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →US Market Access Shifts
6d ago00:07:47Tap to summarizeEpisode 71 — 27 July 2026 Examining US healthcare access pressures, new Alzheimer's treatment formulations, insulin pricing enforcement, and evolving evidence strategies. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →Profit Warning, Approval, Settlement, Expansion
6d ago00:07:54Tap to summarizeEpisode 70 — 26 July 2026 Examining HCA's profit warning impact on US healthcare access, SubQ Leqembi approval HEOR implications, FTC insulin pricing settlement, and ICER scientific advice expansion. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →HCA Profit Warning & SubQ Leqembi
1w ago00:09:09Tap to summarizeEpisode 69 — 25 July 2026 Examining HCA's profit warning signaling U.S. healthcare access pressures, subcutaneous Leqembi's HEOR implications, FTC's insulin pricing settlement, and ICER's expanded scientific advice program. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →Profit Warnings & Pricing Scrutiny
1w ago00:07:35Tap to summarizeEpisode 68 — 24 July 2026 Hospital profit warnings and regulatory settlements signal systemic US healthcare access challenges, while new drug approvals and evidence frameworks evolve rapidly. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →US Access & Evidence Shifts
1w ago00:09:54Tap to summarizeEpisode 67 — 23 July 2026 Examining US healthcare system pressures, novel drug evidence challenges, insulin pricing enforcement, and Medicaid policy shifts shaping market access strategies. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →EMA RWE Pediatric Pilot & CMS Rebate Shift
2w ago00:08:14Tap to summarizeEpisode 66 — 22 July 2026 EMA launches pediatric RWE pilot for rare diseases; ISPOR 2026 highlights PRO framework shifts; CMS proposes Medicaid rebate changes; HTAI-IQVIA launches global RWE database. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →Profit Warnings, Insulin Settlements, and Leqembi
2w ago00:09:27Tap to summarizeEpisode 65 — 21 July 2026 Hospital system financial pressures, insulin pricing settlements, new Alzheimer's formulation approvals, and evolving HTA evidence strategies. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
Transcribe →